Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

WhatsApp-based intervention for people with type 2 diabetes: A randomized controlled trial.

  • Authors : Yaagoob E; School of Nursing and Midwifery, College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, Australia.; Lee R

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/therapy ; Self-Management*/Self-Management*/Self-Management*/methods; Humans

  • Source: Nursing & health sciences [Nurs Health Sci] 2024 Jun; Vol. 26 (2), pp. e13117.Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 100891857 Publication

Record details

×
Academic Journal

Serum vitamin B12, distal symmetrical polyneuropathy and anaemia in type 2 diabetes: the Fremantle Diabetes Study Phase 2.

  • Authors : Davis TME; Division of Internal Medicine, Medical School, University of Western Australia, Perth, Western Australia, Australia.; Chubb SAP

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: Internal medicine journal [Intern Med J] 2024 Apr; Vol. 54 (4), pp. 575-581. Date of Electronic Publication: 2023 Sep 04.Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication

Record details

×
Academic Journal

'We are somehow fixated on this being a diabetes drug': a qualitative study exploring the views of cardiologists and nephrologists about sodium-glucose cotransporter 2 inhibitor initiation.

  • Authors : Milder TY; Department of Diabetes and Endocrinology, St Vincent's Hospital, Sydney, New South Wales, Australia.; Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, New South Wales, Australia.

Subjects: Cardiologists* ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy

  • Source: Internal medicine journal [Intern Med J] 2024 Apr; Vol. 54 (4), pp. 559-567. Date of Electronic Publication: 2023 Aug 07.Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication

Record details

×
Academic Journal

Reporting hypoglycaemia as a hospital-acquired complication: assessing biochemical and clinical validity.

  • Authors : Dharma JFM; Department of Endocrinology and Diabetes, Northern Health, Epping, Victoria, Australia.; Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Hypoglycemia*/Hypoglycemia*/Hypoglycemia*/chemically induced; Humans

  • Source: Internal medicine journal [Intern Med J] 2024 Mar; Vol. 54 (3), pp. 430-437. Date of Electronic Publication: 2023 Jun 05.Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication

Record details

×
Academic Journal

Use of a type 1 genetic risk score for classification of diabetes type in young Australian adults: the Fremantle Diabetes Study Phase II.

  • Authors : Davis TME; Medical School, University of Western Australia, Fremantle Hospital, Fremantle, Western Australia, Australia.; Department of Endocrinology and Diabetes, Fiona Stanley and Fremantle Hospitals Group, Perth, Western Australia, Australia.

Subjects: Australasian People* ; Diabetes Mellitus, Type 1* ; Diabetes Mellitus, Type 2*

  • Source: Internal medicine journal [Intern Med J] 2024 Mar; Vol. 54 (3), pp. 494-498. Date of Electronic Publication: 2024 Jan 15.Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication

Record details

×
Academic Journal

Primary care management post gestational diabetes in Australia.

  • Authors : Marschner S; Westmead Applied Research Centre, The University of Sydney, Sydney, New South Wales, Australia.; Cheung NW

Subjects: Diabetes, Gestational*/Diabetes, Gestational*/Diabetes, Gestational*/diagnosis ; Diabetes, Gestational*/Diabetes, Gestational*/Diabetes, Gestational*/epidemiology ; Diabetes, Gestational*/Diabetes, Gestational*/Diabetes, Gestational*/therapy

  • Source: Internal medicine journal [Intern Med J] 2024 Jan; Vol. 54 (1), pp. 164-171. Date of Electronic Publication: 2023 Jun 22.Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication

Record details

×
Academic Journal

Secular trends in the utility of SGLT-2 inhibitors in heart failure patients with type 2 diabetes mellitus across Metro South Health hospitals in South-East Queensland.

  • Authors : Lu ZQ; Department of Cardiology, Redland Hospital, Brisbane, Queensland, Australia.; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

  • Source: Internal medicine journal [Intern Med J] 2023 Nov; Vol. 53 (11), pp. 2085-2092. Date of Electronic Publication: 2022 Dec 30.Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication

Record details

×
Academic Journal

Tolerability and efficacy of sodium-glucose co-transporter-2 inhibitors in Australian Aboriginal and Torres Strait Islanders with type 2 diabetes mellitus: an observational study.

  • Authors : Fishan N; Department of Diabetes and Endocrinology, Northern Adelaide Local Health Network, Adelaide, South Australia, Australia.; Towers K

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Symporters* ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects

  • Source: Internal medicine journal [Intern Med J] 2023 Oct; Vol. 53 (10), pp. 1916-1918. Date of Electronic Publication: 2023 Oct 04.Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication

Record details

×
  • 1-10 of  82 results for "%22AUSTRALIA%22"